Aclarion announces commercial agreement with spine institute of louisiana

Expands access to first customer using philips mr spectroscopy (mrs), demonstrating ease of nociscan integration across multiple mrs platforms nociscan now commercially available at 17 sites covering eight states and four countries   broomfield, colo., april 29, 2025 (globe newswire) -- aclarion, inc.,  (“aclarion” or the “company”) (nasdaq: acon, aconw), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (ai) algorithms to help physicians identify the location of chronic low back pain, announced today it has established a commercial agreement with the spine institute of louisiana (sil) in shreveport, la.
ACON Ratings Summary
ACON Quant Ranking